
|Articles|February 24, 2017
HIV Treatment Advances Highlight SPT Week in Review
Author(s)Davy James, Managing Editor
Top news of the week from Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/hiv-treatment-advances-highlight-spt-week-in-revie" target="_blank">View the story "HIV Treatment Advances Highlight SPT Week in Review" on Storify</a>]
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Enfortumab Vedotin Plus Pembrolizumab Shows Promise as a Platinum-Free Option in Earlier Bladder Cancer
2
FDA Approves Rucaparib for the Treatment of Adults With mCRPC
3
Updates in Treatment of Unresectable Hepatocellular Carcinoma
4
FDA Approves Amivantamab and Hyaluronidase-lpuj, Revolutionizing Lung Cancer Treatment With 5-Minute Subcutaneous Delivery
5









































































































































































































